<div class="gmail_quote"><div style="word-wrap:break-word"><div><br><blockquote type="cite"><div><div style="margin-top:0px;margin-right:0px;margin-bottom:0px;margin-left:0px"><font face="Helvetica" size="3" color="#000000" style="font:12.0px Helvetica;color:#000000"><b>From: </b></font><font face="Helvetica" size="3" style="font:12.0px Helvetica">"Erin Baumgartner" <<a href="mailto:embaum@MIT.EDU" target="_blank">embaum@MIT.EDU</a>></font></div>
<div style="margin-top:0px;margin-right:0px;margin-bottom:0px;margin-left:0px"><font face="Helvetica" size="3" color="#000000" style="font:12.0px Helvetica;color:#000000"><b>Date: </b></font><font face="Helvetica" size="3" style="font:12.0px Helvetica">October 15, 2009 4:02:33 PM EDT</font></div>
<div style="margin-top:0px;margin-right:0px;margin-bottom:0px;margin-left:0px"><font class="Apple-style-span" face="Helvetica" size="3"><span class="Apple-style-span" style="font-size: 12px;"><b><br></b></span></font></div>
</div><span style="border-collapse:separate;color:rgb(0, 0, 0);font-family:Helvetica;font-size:medium;font-style:normal;font-variant:normal;font-weight:normal;letter-spacing:normal;line-height:normal;text-align:auto;text-indent:0px;text-transform:none;white-space:normal;word-spacing:0px"><div lang="EN-US" link="blue" vlink="blue" style="word-wrap:break-word">
<div><div style="margin-top:0in;margin-right:0in;margin-bottom:0.0001pt;margin-left:0in;font-size:12pt;font-family:'Times New Roman';text-align:center"><font size="3" face="Arial"><span style="font-size:12pt;font-family:Arial">Presentation of: Lyon BioPole and Genzyme</span></font><font size="4" face="Arial"><span style="font-size:14pt;font-family:Arial"><span> </span></span></font><font size="4" face="Arial"><span lang="FR" style="font-size:14pt;font-family:Arial"><img width="146" height="30" alt="genzymelogo" border="0" src="cid:image001.gif@01CA4DB0.E8359910"></span></font><font size="4" face="Arial"><span style="font-size:14pt;font-family:Arial"></span></font></div>
<div style="margin-top:0in;margin-right:0in;margin-bottom:0.0001pt;margin-left:0in;font-size:12pt;font-family:'Times New Roman'"><font size="2" face="Arial"><span style="font-size:10pt;font-family:Arial"> </span></font></div>
<div style="margin-top:0in;margin-right:0in;margin-bottom:0.0001pt;margin-left:0in;font-size:12pt;font-family:'Times New Roman';text-align:center"><b><font size="4" face="Arial"><span style="font-size:14pt;font-family:Arial;font-weight:bold">How to enhance your R&D collaborations with France</span></font></b></div>
<div style="margin-top:0in;margin-right:0in;margin-bottom:0.0001pt;margin-left:0in;font-size:12pt;font-family:'Times New Roman';text-align:center"><font size="4" face="Arial"><span style="font-size:14pt;font-family:Arial"> </span></font></div>
<div style="margin-top:0in;margin-right:0in;margin-bottom:0.0001pt;margin-left:0in;font-size:12pt;font-family:'Times New Roman';text-align:center"><font size="4" face="Arial"><span style="font-size:14pt;font-family:Arial">Experience<span> </span><b><u><span style="font-weight:bold">“<i><span style="font-style:italic">FAST”</span></i></span></u></b></span></font></div>
<div style="margin-top:0in;margin-right:0in;margin-bottom:0.0001pt;margin-left:0in;font-size:12pt;font-family:'Times New Roman';text-align:center"><font size="4" face="Arial"><span style="font-size:14pt;font-family:Arial">Come and network at the<span> </span><b><i><u><span style="font-weight:bold;font-style:italic">“French American Scientific Track”,</span></u></i></b><span> </span>on</span></font></div>
<div style="margin-top:0in;margin-right:0in;margin-bottom:0.0001pt;margin-left:0in;font-size:12pt;font-family:'Times New Roman';text-align:center"><font size="5" face="Arial"><span style="font-size:16pt;font-family:Arial"> </span></font></div>
<div style="margin-top:0in;margin-right:0in;margin-bottom:0.0001pt;margin-left:0in;font-size:12pt;font-family:'Times New Roman';text-align:center;background-repeat:initial;background-color:rgb(51, 153, 51)"><b><font size="5" color="white" face="Arial"><span style="font-size:16pt;font-family:Arial;color:white;font-weight:bold">Therapeutic Proteins,</span></font></b></div>
<div style="margin-top:0in;margin-right:0in;margin-bottom:0.0001pt;margin-left:0in;font-size:12pt;font-family:'Times New Roman';text-align:center;background-repeat:initial;background-color:rgb(51, 153, 51)"><b><font size="5" color="white" face="Arial"><span style="font-size:16pt;font-family:Arial;color:white;font-weight:bold">including Monoclonal Antibodies: New Challenges</span></font></b></div>
<div style="margin-top:0in;margin-right:0in;margin-bottom:0.0001pt;margin-left:0in;font-size:12pt;font-family:'Times New Roman';text-align:center"><font size="5" face="Arial"><span style="font-size:16pt;font-family:Arial"> </span></font></div>
<div style="margin-top:0in;margin-right:0in;margin-bottom:0.0001pt;margin-left:0in;font-size:12pt;font-family:'Times New Roman';text-align:center"><b><font size="4" face="Arial"><span style="font-size:14pt;font-family:Arial;font-weight:bold">Tuesday, October 27<sup>th</sup><span> </span>2009, at the<span> </span>Genzyme<span> </span>Center, 5.30 to 7.30 pm</span></font></b></div>
<div style="margin-top:0in;margin-right:0in;margin-bottom:0.0001pt;margin-left:0in;font-size:12pt;font-family:'Times New Roman';text-align:center"><font size="2" face="Arial"><span style="font-size:11pt;font-family:Arial">The Roscoe Brady lecture Hall,<span> </span>500 Kendall Street,<span> </span>Cambridge,<span> </span>MA<span> </span>02142</span></font></div>
<div style="margin-top:0in;margin-right:0in;margin-bottom:0.0001pt;margin-left:0in;font-size:12pt;font-family:'Times New Roman';text-align:center"><font size="4" face="Arial"><span style="font-size:14pt;font-family:Arial"> </span></font></div>
<div style="margin-top:0in;margin-right:0in;margin-bottom:0.0001pt;margin-left:0in;font-size:12pt;font-family:'Times New Roman'"><font size="2" face="Arial"><span style="font-size:10pt;font-family:Arial"> </span></font></div>
<div style="margin-top:0in;margin-right:0in;margin-bottom:0.0001pt;margin-left:0in;font-size:12pt;font-family:'Times New Roman';background-repeat:initial;background-color:rgb(191, 191, 191)"><b><font size="3" face="Arial"><span style="font-size:12pt;font-family:Arial;font-weight:bold">Program</span></font></b></div>
<div style="margin-top:0in;margin-right:0in;margin-bottom:0.0001pt;margin-left:0in;font-size:12pt;font-family:'Times New Roman'"><font size="2" face="Arial"><span style="font-size:10pt;font-family:Arial"> </span></font></div>
<div style="margin-top:0in;margin-right:0in;margin-bottom:0.0001pt;margin-left:0in;font-size:12pt;font-family:'Times New Roman'"><font size="2" face="Arial"><span style="font-size:10pt;font-family:Arial">5.30 – 7.00 pm: <span> </span><b><span style="font-weight:bold">Presentations</span></b></span></font></div>
<div style="margin-top:0in;margin-right:0in;margin-bottom:0.0001pt;margin-left:0in;font-size:12pt;font-family:'Times New Roman'"><font size="2" face="Arial"><span style="font-size:10pt;font-family:Arial"> </span></font></div>
<div style="margin-top:0in;margin-right:0in;margin-bottom:0.0001pt;margin-left:0in;font-size:12pt;font-family:'Times New Roman'"><font size="2" face="Arial"><span style="font-size:10pt;font-family:Arial">Dan Snell, Ph.D., Associate Director, Antibody Therapeutics,<span> </span><b><span style="font-weight:bold">Genzyme</span></b>,<span> </span>Cambridge,<span> </span>UK</span></font></div>
<div style="margin-top:0in;margin-right:0in;margin-bottom:0.0001pt;margin-left:0in;font-size:12pt;font-family:'Times New Roman'"><b><i><font size="2" face="Arial"><span lang="EN-GB" style="font-size:10pt;font-family:Arial;font-weight:bold;font-style:italic">Towards the next generation of biopharmaceuticals.</span></font></i></b></div>
<div style="margin-top:0in;margin-right:0in;margin-bottom:0.0001pt;margin-left:0in;font-size:12pt;font-family:'Times New Roman'"><font size="2" face="Arial"><span lang="EN-GB" style="font-size:10pt;font-family:Arial"> </span></font></div>
<div style="margin-top:0in;margin-right:0in;margin-bottom:0.0001pt;margin-left:0in;font-size:12pt;font-family:'Times New Roman'"><font size="2" face="Arial"><span style="font-size:10pt;font-family:Arial">Maud Bouvier, Ph.D., Business Development Manager,<span> </span><b><span style="font-weight:bold">ERYtech Pharma</span></b>,<span> </span>Lyon,<span> </span>France</span></font></div>
<div style="margin-top:0in;margin-right:0in;margin-bottom:0.0001pt;margin-left:0in;font-size:12pt;font-family:'Times New Roman'"><b><i><font size="2" face="Arial"><span lang="EN-GB" style="font-size:10pt;font-family:Arial;font-weight:bold;font-style:italic">Protein immune tolerance induction: an Innovative solution</span></font></i></b></div>
<div style="margin-top:0in;margin-right:0in;margin-bottom:0.0001pt;margin-left:0in;font-size:12pt;font-family:'Times New Roman'"><font size="2" face="Arial"><span style="font-size:10pt;font-family:Arial"> </span></font></div>
<div style="margin-top:0in;margin-right:0in;margin-bottom:0.0001pt;margin-left:0in;font-size:12pt;font-family:'Times New Roman'"><font size="2" face="Arial"><span lang="EN-GB" style="font-size:10pt;font-family:Arial">Janice Reichert, Ph.D., Senior Research Fellow,<span> </span><b><span style="font-weight:bold">Tufts CSDD</span></b>, and Editor-in-Chief of mAbs,<span> </span><b><span style="font-weight:bold">Tufts</span></b><b><span style="font-weight:bold"><span> </span>University</span></b>, publisher of mAbs is Landes Bioscience,<span> </span>Boston,<span> </span>USA</span></font></div>
<div style="margin-top:0in;margin-right:0in;margin-bottom:0.0001pt;margin-left:0in;font-size:12pt;font-family:'Times New Roman'"><b><i><font size="2" face="Arial"><span lang="EN-GB" style="font-size:10pt;font-family:Arial;font-weight:bold;font-style:italic">Monoclonal antibodies in the pharma landscape: new directions and challenges</span></font></i></b><font size="2" face="Arial"><span style="font-size:10pt;font-family:Arial"></span></font></div>
<div style="margin-top:0in;margin-right:0in;margin-bottom:0.0001pt;margin-left:0in;font-size:12pt;font-family:'Times New Roman'"><font size="2" face="Arial"><span style="font-size:10pt;font-family:Arial"> </span></font></div>
<div style="margin-top:0in;margin-right:0in;margin-bottom:0.0001pt;margin-left:0in;font-size:12pt;font-family:'Times New Roman'"><font size="2" face="Arial"><span style="font-size:10pt;font-family:Arial">Gabriel Baverel Ph.D.,<span> </span><b><span style="font-weight:bold">Metabolys</span></b>, CEO,<span> </span>Lyon,<span> </span>France</span></font></div>
<div style="margin-top:0in;margin-right:0in;margin-bottom:0.0001pt;margin-left:0in;font-size:12pt;font-family:'Times New Roman'"><b><i><font size="2" face="Arial"><span lang="EN-GB" style="font-size:10pt;font-family:Arial;font-weight:bold;font-style:italic">Cellular metabolomics : a precious tool to predict the safety of drug candidates and biologics</span></font></i></b><font size="2" face="Arial"><span lang="EN-GB" style="font-size:10pt;font-family:Arial"></span></font><font size="2" face="Arial"><span style="font-size:10pt;font-family:Arial"></span></font></div>
<div style="margin-top:0in;margin-right:0in;margin-bottom:0.0001pt;margin-left:0in;font-size:12pt;font-family:'Times New Roman'"><font size="2" face="Arial"><span style="font-size:10pt;font-family:Arial"> </span></font></div>
<div style="margin-top:0in;margin-right:0in;margin-bottom:0.0001pt;margin-left:0in;font-size:12pt;font-family:'Times New Roman'"><font size="2" face="Arial"><span style="font-size:10pt;font-family:Arial">Antu Dey, Ph.D., Investigator, Protein Biochemistry, Vaccines & Diagnostics Division,<span> </span><b><span style="font-weight:bold">Novartis</span></b>,<span> </span>Cambridge,<span> </span>USA</span></font></div>
<div style="margin-top:0in;margin-right:0in;margin-bottom:0.0001pt;margin-left:0in;font-size:12pt;font-family:'Times New Roman'"><b><i><font size="2" face="Arial"><span lang="EN-GB" style="font-size:10pt;font-family:Arial;font-weight:bold;font-style:italic">Developing monoclonal antibodies against viral targets & challenges therewith</span></font></i></b></div>
<div style="margin-top:0in;margin-right:0in;margin-bottom:0.0001pt;margin-left:0in;font-size:12pt;font-family:'Times New Roman'"><font size="2" face="Arial"><span style="font-size:10pt;font-family:Arial"> </span></font></div>
<div style="margin-top:0in;margin-right:0in;margin-bottom:0.0001pt;margin-left:0in;font-size:12pt;font-family:'Times New Roman'"><font size="2" face="Arial"><span style="font-size:10pt;font-family:Arial">Tristan Rousselle, Ph.D., CEO & co-Founder,<b><span style="font-weight:bold"><span> </span>PX Therapeutics</span></b>,<span> </span>Grenoble<span> </span>France</span></font></div>
<div style="margin-top:0in;margin-right:0in;margin-bottom:0.0001pt;margin-left:0in;font-size:12pt;font-family:'Times New Roman'"><b><i><font size="2" face="Arial"><span lang="EN-GB" style="font-size:10pt;font-family:Arial;font-weight:bold;font-style:italic">Main issues for the development of biologics, from bench to GMP production</span></font></i></b><font size="2" face="Arial"><span style="font-size:10pt;font-family:Arial"></span></font></div>
<div style="margin-top:0in;margin-right:0in;margin-bottom:0.0001pt;margin-left:0in;font-size:12pt;font-family:'Times New Roman'"><font size="2" face="Arial"><span style="font-size:10pt;font-family:Arial"> </span></font></div>
<div style="margin-top:0in;margin-right:0in;margin-bottom:0.0001pt;margin-left:0in;font-size:12pt;font-family:'Times New Roman'"><font size="2" face="Arial"><span style="font-size:10pt;font-family:Arial"> </span></font></div>
<div style="margin-top:0in;margin-right:0in;margin-bottom:0.0001pt;margin-left:0in;font-size:12pt;font-family:'Times New Roman'"><b><font size="2" face="Arial"><span style="font-size:10pt;font-family:Arial;font-weight:bold">IF INTERESTED CONTACT:</span></font></b></div>
<div style="margin-top:0in;margin-right:0in;margin-bottom:0.0001pt;margin-left:0in;font-size:12pt;font-family:'Times New Roman'"><font size="2" face="Arial"><span style="font-size:10pt;font-family:Arial"><br>Erin Baumgartner</span></font></div>
<div style="margin-top:0in;margin-right:0in;margin-bottom:0.0001pt;margin-left:0in;font-size:12pt;font-family:'Times New Roman'"><font size="2" face="Arial"><span style="font-size:10pt;font-family:Arial">MIT<span> </span>France<span> </span>Program</span></font></div>
<div style="margin-top:0in;margin-right:0in;margin-bottom:0.0001pt;margin-left:0in;font-size:12pt;font-family:'Times New Roman'"><font size="2" face="Arial"><span style="font-size:10pt;font-family:Arial"><a href="mailto:embaum@mit.edu" style="color:blue;text-decoration:underline" target="_blank">embaum@mit.edu</a></span></font><font size="2" face="Arial"><span style="font-size:10pt;font-family:Arial"></span></font></div>
<div style="margin-top:0in;margin-right:0in;margin-bottom:0.0001pt;margin-left:0in;font-size:12pt;font-family:'Times New Roman'"><font size="2" color="navy" face="Arial"><span style="font-size:10pt;font-family:Arial;color:navy"> </span></font></div>
<div style="margin-top:0in;margin-right:0in;margin-bottom:0.0001pt;margin-left:0in;font-size:12pt;font-family:'Times New Roman'"><font size="2" color="navy" face="Arial"><span style="font-size:10pt;font-family:Arial;color:navy"> </span></font></div>
<div><div style="margin-top:0in;margin-right:0in;margin-bottom:0.0001pt;margin-left:0in;font-size:12pt;font-family:'Times New Roman'"><font size="2" color="navy" face="Arial"><span style="font-size:10pt;font-family:Arial;color:navy">Erin Baumgartner</span></font><font color="navy"><span style="color:navy"></span></font></div>
<div style="margin-top:0in;margin-right:0in;margin-bottom:0.0001pt;margin-left:0in;font-size:12pt;font-family:'Times New Roman'"><font size="2" color="navy" face="Arial"><span style="font-size:10pt;font-family:Arial;color:navy">Program Coordinator</span></font><font color="navy"><span style="color:navy"></span></font></div>
<div style="margin-top:0in;margin-right:0in;margin-bottom:0.0001pt;margin-left:0in;font-size:12pt;font-family:'Times New Roman'"><font size="2" color="navy" face="Arial"><span style="font-size:10pt;font-family:Arial;color:navy">MIT-France Program</span></font><font color="navy"><span style="color:navy"></span></font></div>
<div style="margin-top:0in;margin-right:0in;margin-bottom:0.0001pt;margin-left:0in;font-size:12pt;font-family:'Times New Roman'"><font size="2" color="navy" face="Arial"><span style="font-size:10pt;font-family:Arial;color:navy">Building E40-421</span></font><font color="navy"><span style="color:navy"></span></font></div>
<div style="margin-top:0in;margin-right:0in;margin-bottom:0.0001pt;margin-left:0in;font-size:12pt;font-family:'Times New Roman'"><font size="2" color="navy" face="Arial"><span style="font-size:10pt;font-family:Arial;color:navy">Massachusetts Institute of Technology</span></font><font color="navy"><span style="color:navy"></span></font></div>
<div style="margin-top:0in;margin-right:0in;margin-bottom:0.0001pt;margin-left:0in;font-size:12pt;font-family:'Times New Roman'"><font size="2" color="navy" face="Arial"><span style="font-size:10pt;font-family:Arial;color:navy">77 Massachusetts Avenue</span></font><font color="navy"><span style="color:navy"></span></font></div>
<div style="margin-top:0in;margin-right:0in;margin-bottom:0.0001pt;margin-left:0in;font-size:12pt;font-family:'Times New Roman'"><font size="2" color="navy" face="Arial"><span style="font-size:10pt;font-family:Arial;color:navy">Cambridge</span></font><font size="2" color="navy" face="Arial"><span style="font-size:10pt;font-family:Arial;color:navy">,<span> </span>MA<span> </span>02139</span></font><font color="navy"><span style="color:navy"></span></font></div>
<div style="margin-top:0in;margin-right:0in;margin-bottom:0.0001pt;margin-left:0in;font-size:12pt;font-family:'Times New Roman'"><font size="2" color="navy" face="Arial"><span style="font-size:10pt;font-family:Arial;color:navy">(617) 253-8813</span></font><font color="navy"><span style="color:navy"></span></font></div>
<div style="margin-top:0in;margin-right:0in;margin-bottom:0.0001pt;margin-left:0in;font-size:12pt;font-family:'Times New Roman'"><font size="2" color="navy" face="Arial"><span style="font-size:10pt;font-family:Arial;color:navy"><a href="mailto:embaum@mit.edu" style="color:blue;text-decoration:underline" target="_blank">embaum@mit.edu</a></span></font><font color="navy"><span style="color:navy"></span></font></div>
<div style="margin-top:0in;margin-right:0in;margin-bottom:0.0001pt;margin-left:0in;font-size:12pt;font-family:'Times New Roman'"><font size="3" color="navy" face="Times New Roman"><span style="font-size:12pt;color:navy"> </span></font></div>
</div></div></div></span></blockquote></div></div></div>